The review said a certain class of drugs had little clinical benefit, but many Alzheimer’s experts criticized the analysis, saying it unfairly lumped failed drugs with two recently approved treatments.
Source link
Trending
- Artemis II Crew Discusses NASA Moon Mission and Next Steps
- Tell us: do you use AI for fitness? | Fitness
- Surprise tornadoes in Kansas prompt concerns about changes at National Weather Service
- Ready, set, ride! Everything you need to cycle with kids | Cycling
- Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
- In Defense of Dumb Dogs
- Nature Is Still Molding Human Genes, Study Finds
- Whydah Gally Shipwreck Corrects a Myth About African Gold
Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness
MOST. JESMIN AKTER
Hi , I am MOST JESMIN AKTER . I am Journalist , I am News Reporter of The MoorningTimes Online News Portal
Add A Comment
